Is a
Patent attributes
Patent Applicant
0
Current Assignee
0
Patent Jurisdiction
Patent Number
Date of Patent
January 31, 2023
0Patent Application Number
169469840
Date Filed
July 14, 2020
0Patent Citations
Patent Primary Examiner
The invention provides methods of treating an allergic inflammatory condition characterized by inflammation of the squamous epithelium of a target tissue by administering to the subject a pharmaceutical composition comprising a kallikrein 5 (KLK5) inhibitor, and a pharmaceutically acceptable carrier.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.